West Pharmaceutical Services Inc. (WST) Dividend Safety Gauge & 10-Year DRIP Compounder

$416.67 +3.23% NYSE • Public Delayed / 60s Snapshot

West Pharmaceutical Services Inc. (WST) earns a Roarable Rating of B- (Buy) with 70/100 RQD Confidence. High-quality cash engine (36% profit margin, 18% return on capital) with steady institutional support. Even if the broader market gets choppy, the company’s underlying cash engine and big-money support put the odds in buyers’ favor.

ROARABLE B- • BUY Cap $29.32B
INTERACTIVE SCENARIO DECK:
🛡️ Portfolio Crash X-Ray
RQD QUANT TACHOMETERBUY • B-
025507510070
2-of-3 JEV AI Jury Bullish
Cash
SEC
Whale
5-PILLAR SNOWFLAKE RADARRw C+ · Rk B
Cash (18)Whales (10)SEC (16)Macro (14)CEO (12)
Each axis scored 0–20
12M PRICE TARGET CONE+5.4% Base Target
$518 Bull$439 Base$342 Bear
🔴 SUNDAY NIGHT PREP • 7:00 PM ET
WHALE OPTIONS TUG-OF-WAR:60% Call Buyers ($3.2M)
40% PutsMax Pain: $408.00
CASH DIVIDEND + BUYBACK YIELD
0.81% Total Yield
0.21% Cash ($0.88/yr) + 0.6% Buybacks
PAYOUT SAFETY SPEEDOMETER
88/100 • FORTRESS PAYOUT
FREE CASH FLOW PAYOUT RATIO
14% of FCF
8 consecutive years of payout growth
INTERACTIVE DRIP & SHAREHOLDER-YIELD COMPOUNDER (5.5% EST. ANNUAL)

$10,000 Compounded Over 10 Years → $17,081

Est. Year-10 Shareholder Yield: $138/yr
$10.6K
Yr 1
$11.1K
Yr 2
$11.7K
Yr 3
$12.4K
Yr 4
$13.1K
Yr 5
$13.8K
Yr 6
$14.5K
Yr 7
$15.3K
Yr 8
$16.2K
Yr 9
$17.1K
Yr 10
🔴 SUNDAY NIGHT PREP • 7:00 PM ETHosted Live by Perry Belcher + Senior Cash-Flow & Income Strategist

Cash-Fortress Compounders: Collecting Safe Yield & Upside in WST & Top A-Rated Leaders

  • ✓12-month Bull/Base/Bear fair-value walkthrough on WST and its top sector rival
  • ✓The Top 5 Roarable A-Rated cash compounders with heavy executive & 13F accumulation
  • ✓Includes free daily Morning Market Weather & signal upgrade/downgrade dispatch
RQD INSIDER CLUB UPGRADE$49/YEAR
Want Plain-English AI Custom Indicators, Daily Pro Trader Video Clips & SMS Crash Alerts?
WST // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +38.65%▲ ASCENDING CHANNEL
2026-10-30O $419.1H $422.1L $407.7C $412.6VOL 1.06M
RES: $463.2SUP: $348.0SMA50: $367.6SMA200: $313.4
$451.0$398.4$345.8$293.2$240.6RES $463.2SUP $348.0$412.62026-04-302026-06-152026-07-312026-09-162026-10-30
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

WST Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)
41.2%/yr Implied 5Y Growth

vs. +6.3% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on WST today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →
WST → LLY Confirmed Filing
West Pharmaceutical Services manufactures NovaPure fluoropolymer-coated elastomer plungers and cartridge seals required inside sterile single-dose and multi-dose GLP-1 auto-injector pens.
AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for WST today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

WST Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

Does WST pay a dividend and is it safe?

West Pharmaceutical Services Inc. (WST) offers a 0.21% cash dividend yield ($0.88 annualized) and 0.81% total shareholder yield including buybacks. Roarable rates its payout coverage as FORTRESS PAYOUT.